Plain-English translation of NCT06876662 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This is a follow-up study for people who already participated in an earlier research trial testing for chronic lymphocytic leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma. If you were in that original study and benefiting from the medication, you may be able to continue taking it through this new study while doctors keep track of how it's working and any side effects.
The original study has ended, but researchers want to keep watching people who are doing well on this medication to understand its long-term safety and effectiveness. This lets patients continue treatment without interruption while providing important information for future patients.
You likely qualify if…
You likely don't qualify if…
You would continue taking the same medication you were already on in the original study, in pill form by mouth. You would attend follow-up visits as scheduled to let doctors check how you're doing, monitor for any side effects, and see how well the treatment is working. The study is designed to collect safety and effectiveness information over the long term while you receive ongoing care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States